• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Endocrinology

No significant long-term size change in benign thyroid nodules

byReshmi MadankumarandPriyanka Vedak
March 4, 2015
in Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The majority of benign thyroid nodules did not significantly increase in size during a 5-year follow-up period.

2. While a minority of patients experienced new nodule growth, the diagnosis of thyroid cancer was rare.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The increase in detection of asymptomatic thyroid nodules has paralleled the improvement in imaging techniques. Existing guidelines for cytologically benign or sonographically unsuspicious thyroid nodules recommends serial ultrasound exams to assess for significant growth, defined as ≥20% increase in ≥2 nodule diameters, with a minimum increase of 2 mm. If growth is observed, cytological assessment is warranted. However, the natural history of benign thyroid nodules, the likelihood of their growth and their malignant potential is not well elucidated.

This study aimed to gauge the natural history of benign thyroid nodules by follow-up. It was found that the majority of nodules were stable in size, with a minority experiencing significant growth and a subset experiencing shrinkage. Nodule growth was associated with multinodular disease, larger nodules at baseline and younger age. A very small minority of patients was diagnosed with thyroid cancer in the nodules being followed. The strengths of this study include its size and prospective design but it is limited by its predictive modeling. Iodine intake influences thyroid nodules. The study population was from Italy; therefore, the findings are difficult to generalize to other populations. Nevertheless, the findings support a revision to current guidelines to recommend an ultrasound exam performed 1 year and 5 years after detection of a benign thyroid nodule (given that no changes are noted). Closer follow-up can be considered in patients more likely to experience nodule growth.

Click to read the study, published today in JAMA

RELATED REPORTS

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

More permissive parameters for active surveillance eligibility is potentially possible in slow-growing thyroid cancers

Click to read an accompanying editorial in JAMA

Relevant Reading: Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

In-Depth [prospective cohort]: This study prospectively enrolled 992 patients with 1 to 4 asymptomatic thyroid nodules, studying a total of 1,567 nodules at baseline. Patients were followed up with ultrasound exam yearly for 5 years. Sixty-nine percent of patients experienced stable size of their nodules, 18.5% (95%CI 16.4%-20.9%) experienced shrinkage of ≥1 nodules, and 15.4% (95%CI 14.3%-16.5%) experienced significant growth. Of the 1,567 nodules at baseline, 11.1% (95%CI 10.3%-11.9%) increased in size. Ninety-three patients (9.3%; 95%CI 8.4%-10.2%) developed new nodules. Thyroid cancer was diagnosed in 5 of the original nodules (0.3%; 95%CI 0.2%-0.4%). Statistical analysis revealed several factors associated with nodule growth, with older patients with multinodular disease and largest nodule size exceeding 7.5 mm having the highest chances of nodule growth during follow-up.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: thyroid cancer
Previous Post

Double-lung transplantation associated with lower mortality in IPF

Next Post

Novel compound may correct pathological airway mucus in cystic fibrosis [PreClinical]

RelatedReports

#VisualAbstract: Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
StudyGraphics

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

November 24, 2023
Patient Basics: Thyroid Cancer
Chronic Disease

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

October 19, 2022
Oncology

More permissive parameters for active surveillance eligibility is potentially possible in slow-growing thyroid cancers

September 26, 2022
#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers
StudyGraphics

#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers

December 20, 2022
Next Post
Novel compound may correct pathological airway mucus in cystic fibrosis [PreClinical]

Novel compound may correct pathological airway mucus in cystic fibrosis [PreClinical]

Paracetamol (Tylenol) ineffective for low-back pain [PACE Study]

Risks of long-term tylenol use corroborated in meta-analysis

Classics Series, Landmark Trials in Medicine

Omeprazole before endoscopy in patients with gastrointestinal bleeding [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
  • Early induction of labour reduces shoulder dystocia rates in large for gestational age fetuses
  • Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.